Real-Life Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany

被引：0
|
作者：
Dworak, Markus
Gruenberger, Jean-Bernard
Bader, Giovanni
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1101-P
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [1] EFFECTIVENESS OF VILDAGLIPTIN COMPARED TO SULFONYLUREAS IN TYPE 2 DIABETES PATIENTS IN GERMANY: RESULTS FROM A LARGE REAL-LIFE COHORT STUDY
    Dworak, M.
    Gruenberger, J. B.
    Bader, G.
    VALUE IN HEALTH, 2012, 15 (07) : A495 - A495
  • [2] Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany
    Goke, R.
    Gruenberger, J. B.
    Bader, G.
    Dworak, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 785 - 789
  • [3] Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany
    Goeke, Ruediger
    Bader, Giovanni
    Dworak, Markus
    DIABETES THERAPY, 2014, 5 (01) : 183 - 191
  • [4] Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany
    Rüdiger Göke
    Giovanni Bader
    Markus Dworak
    Diabetes Therapy, 2014, 5 : 183 - 191
  • [5] Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study
    Nilsson, P. M.
    Brath, H.
    Penfornis, A.
    de Castro, J. J.
    Conget, I.
    Goeke, R.
    Pagkalos, E.
    Schaper, N. C.
    Geransar, P.
    Bader, G.
    Paldanius, P. M.
    Barnett, A. H.
    Mathieu, C.
    DIABETOLOGIA, 2014, 57 : S366 - S366
  • [6] Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study
    Ayvaz, Goksun
    Keskin, Lezzan
    Akin, Fulya
    Dokmetas, Hatice Sebile
    Tasan, Ertugrul
    Ar, Idilhan Baloglu
    Uren, Emel
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 623 - 632
  • [7] Real-Life Investigation of Effectiveness and Tolerability of Hydroxychloroquine in Type 2 Diabetes Mellitus Patients in India
    Chawla, Manoj S.
    Chawla, Purvi M.
    Gupta, Payal
    DIABETES, 2018, 67
  • [8] Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
    Dominique Simon
    Bruno Detournay
    Evelyne Eschwege
    Stephane Bouée
    Jacques Bringer
    Claude Attali
    Sylvie Dejager
    Diabetes Therapy, 2014, 5 : 207 - 224
  • [9] Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
    Simon, Dominique
    Detournay, Bruno
    Eschwege, Evelyne
    Bouee, Stephane
    Bringer, Jacques
    Attali, Claude
    Dejager, Sylvie
    DIABETES THERAPY, 2014, 5 (01) : 207 - 224
  • [10] Cost-effectiveness of metformin plus vildagliptin versus metformin plus sulphonylurea for the treatment of type 2 diabetes: a real-life perspective
    Viana, R.
    Agrawal, R.
    Ong, S. -H.
    Paldanius, P. M.
    Partha, G.
    DIABETOLOGIA, 2015, 58 : S482 - S482
12345